Neurofibromatosis type 1 (NF1), NF2, and schwannomatosis constitute a group of related tumor suppressor syndromes unified by the predisposition to nerve sheath tumors. These patients harbor germline inactivating mutations in tumor suppressor genes (first-hit) and develop tumors when tissues acquire a second somatic mutation in the remaining allele (second-hit). Despite the overlap between these disorders, there are many differences in the phenotype and management of these patients. This chapter reviews the clinical and genetic aspects of these related disorders. © 2010 Springer Science+Business Media, LLC.
CITATION STYLE
Smith, M. J., & Plotkin, S. R. (2010). Neurofibromatosis and schwannomatosis. In Principles of Clinical Cancer Genetics: A Handbook from the Massachusetts General Hospital (pp. 181–193). Springer US. https://doi.org/10.1007/978-0-387-93846-2_13
Mendeley helps you to discover research relevant for your work.